The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis

Figure 8

Forest plot of the overall survival (OS) of metformin use in patients with three main types of urinary system cancer: kidney cancer (a); bladder cancer (b); prostate cancer (c).

(a)

(b)

(c)